MIP
REGN icon

Marietta Investment Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Marietta Investment Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-624
Closed -$339K – 137
2015
Q4 		$339K Buy
+624
New +$338K 0.14% 101

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Marietta Investment Partners's REGN Position: Q1 2016 in Review

Marietta Investment Partners sold out of Regeneron Pharmaceuticals (REGN) in Q1 2016, closing a stake of 624 shares — an estimated $339K sold.

Marietta Investment Partners first reported a position in REGN in Q4 2015 and held it in 1 quarter. The position peaked at $339K in Q4 2015. 549 funds tracked by Wall St. Rank hold REGN as of Q1 2016.

  • Marietta Investment Partners reported no remaining Regeneron Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Marietta Investment Partners sold 624 Regeneron Pharmaceuticals shares in Q1 2016, an estimated $339K.
  • Marietta Investment Partners first reported a position in Regeneron Pharmaceuticals in Q4 2015 and held it in 1 quarter.
  • Marietta Investment Partners's Regeneron Pharmaceuticals position peaked at $339K in Q4 2015.
  • 549 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2016.

Based on Marietta Investment Partners's 13F filing for Q1 2016, filed 10 May 2016.